An international study, involving Newcastle University, has for the first time found a genetic marker in tumors from patients with high-risk neuroblastoma.
Jun 21, 2021
0
4
DEAR MAYO CLINIC: A friend of mine shared that she went for her annual mammogram last week. At the appointment, she was asked whether she had been vaccinated for COVID-19 and had experienced any changes in her breasts. I ...
May 11, 2021
0
2
New insights into the three-dimensional (3D) morphology of the human uterine endometrium could advance the understanding of the mechanisms of endometrial regeneration and fertilized egg implantation while clarifying the pathogenesis ...
Apr 13, 2021
0
0
Low doses of propylparaben—an estrogen-like chemical used as a preservative in personal care products and foods—can alter pregnancy-related changes in the breast in ways that may reduce the normal protection against breast ...
Mar 16, 2021
0
1
Hormones produced by the thyroid gland are essential regulators of organ function. The absence of these hormones either through thyroid dysfunction due to, for example, irradiation, thyroid cancer or autoimmune disease or ...
Mar 11, 2021
0
10
Researchers at the Vanderbilt Institute for Surgery and Engineering have developed a minuscule robot that could revolutionize surgical procedures for treating prostate cancer, which affects one in nine men in the United States. ...
Feb 11, 2021
0
4
The largest single cell study to date of the childhood cancer, neuroblastoma, has answered important questions about the genesis of the disease. The researchers from the Wellcome Sanger Institute, Great Ormond Street Hospital ...
Feb 5, 2021
0
46
Researchers at the Center for Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University have preliminarily validated an artificial intelligence (AI) tool to predict how likely the disease ...
Jan 15, 2021
0
17
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic resonance imaging, or MRI, frequently underestimates the size of prostate tumors, potentially leading to undertreatment.
Jan 7, 2021
0
2
Orgovyx (relugolix) is now approved to treat advanced prostate cancer and is the first oral hormone therapy approved for this indication, the U.S. Food and Drug Administration announced Friday.
Dec 22, 2020
0
7
